AstraZeneca’s Lynparza shows promising results in phase 3 ovarian cancer trial
AstraZeneca has reported significant findings from its phase 3 trial, SOLO-2, for its ovarian cancer drug Lynparza (olaparib), demonstrating considerable improvement in survival chances for ... Read More
Apollo Cancer Hospital launches Tomotheraphy for high-end cancer care
Apollo Cancer Institute in Hyderabad launched a highest precision cancer care called as Tomotherapy. Considered to be the latest innovation in high-end cancer care treatment, ... Read More